Advertisement

July 13, 2020

Edwards and Abbott Settle Global Transcatheter Litigation

July 13, 2020—Edwards Lifesciences Corporation and Abbott separately announced that they have reached an agreement to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products.

According to both companies, the agreement will result in the dismissal of all pending cases or appeals in courts and patent offices worldwide, and it includes a provision that the parties will not litigate patent disputes with each other in the field of transcatheter mitral and tricuspid repair and replacement products for the 10-year duration of the agreement. Any injunctions currently in place will be lifted. Specifically, Abbott noted that the injunctions currently in place against the sale of Edwards’ transcatheter mitral and tricuspid repair system will be lifted.

Details of the settlement are confidential, advised both Edwards and Abbott.

Advertisement


July 14, 2020

Penumbra Appoints Medical and Scientific Leadership

July 13, 2020

One-Year Follow-Up Completed in PIONEER-III Trial of Sinomed’s Buma Supreme DES